Jason S. Carter

General Counsel, Vera Therapeutics, Inc.

Companies

Vera Therapeutics, Inc.General counsel Nov 20, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vera Therapeutics, Inc. VERA49,136 shares²$1.4M at $29.04Nov 21, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 21, 2025Sold 3,864 shares at $27.82 of Vera Therapeutics, Inc.²
Nov 18, 2024Granted 53,000 shares of Vera Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARVera Therapeutics, Inc., General counsel
2
SEC EDGARVera Therapeutics, Inc. shares after the filing of Nov 21, 2025
3
SEC EDGARForm 4 filed Nov 20, 2024